Search research articles
Contact Us
Filters
Showing results (11-20 of 21) with videos related to
Page
of 3
Sort By:
International Journal of Radiation Oncology, Biology, Physics
|
June 10, 2008
Oxaliplatin and capecitabine-based chemoradiotherapy for gastric cancer--an extended phase I MARGIT and AIO trial
Ralf-Dieter Hofheinz, Frederik Wenz, Nadine Lukan, et al.
Journal of Cancer Research and Clinical Oncology
|
August 7, 2013
Cetuximab-induced skin exanthema: prophylactic and reactive skin therapy are equally effective
Thomas C Wehler, Claudine Graf, Markus Möhler, et al.
Journal of Gastrointestinal and Liver Diseases : JGLD
|
October 29, 2020
Pilot Study on Malnutrition and DNA Damage in Patients with Newly Diagnosed Gastrointestinal Tumors: Is DNA Damage Reversible by Early Individualized Nutritional Support?
Liana M Bergholz, Peter Grimminger, Elsa Dikeoulia, et al.
Cancers
|
July 9, 2022
Integrative Analysis of Intrahepatic Cholangiocarcinoma Subtypes for Improved Patient Stratification: Clinical, Pathological, and Radiological Considerations
Tiemo S Gerber, Lukas Müller, Fabian Bartsch, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine
|
March 15, 2018
Cytokeratin-18 fragments predict treatment response and overall survival in gastric cancer in a randomized controlled trial
Michael Nagel, Julia Schulz, Annett Maderer, et al.
Journal of Cancer Research and Clinical Oncology
|
March 13, 2017
HER2 testing in gastric cancer: results of a German expert meeting
Florian Lordick, Salah-Eddin Al-Batran, Manfred Dietel, et al.
Eclinicalmedicine
|
May 28, 2026
Tislelizumab plus chemotherapy versus placebo plus chemotherapy as first-line treatment in patients with advanced gastric or gastroesophageal junction adenocarcinoma, with or without peritoneal metastases: a post-hoc analysis on RATIONALE-305 study
Miao-Zhen Qiu, Keun-Wook Lee, Markus Möhler, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association
|
October 17, 2023
German, Austrian, and Swiss guidelines for systemic treatment of gastric cancer
Florian Lordick, Salah-Eddin Al-Batran, Dirk Arnold, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 12, 2015
Impact of Subsequent Therapies on Outcome of the FIRE-3/AIO KRK0306 Trial: First-Line Therapy With FOLFIRI Plus Cetuximab or Bevacizumab in Patients With KRAS Wild-Type Tumors in Metastatic Colorectal Cancer
Dominik P Modest, Sebastian Stintzing, Ludwig Fischer von Weikersthal, et al.
BMC Cancer
|
April 13, 2012
LICC: L-BLP25 in patients with colorectal carcinoma after curative resection of hepatic metastases: a randomized, placebo-controlled, multicenter, multinational, double-blinded phase II trial
Carl Christoph Schimanski, Markus Möhler, Michael Schön, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 21) with videos related to
Sort By:
Page
of 3
International Journal of Radiation Oncology, Biology, Physics
|
June 10, 2008
Oxaliplatin and capecitabine-based chemoradiotherapy for gastric cancer--an extended phase I MARGIT and AIO trial
Ralf-Dieter Hofheinz, Frederik Wenz, Nadine Lukan, et al.
Journal of Cancer Research and Clinical Oncology
|
August 7, 2013
Cetuximab-induced skin exanthema: prophylactic and reactive skin therapy are equally effective
Thomas C Wehler, Claudine Graf, Markus Möhler, et al.
Journal of Gastrointestinal and Liver Diseases : JGLD
|
October 29, 2020
Pilot Study on Malnutrition and DNA Damage in Patients with Newly Diagnosed Gastrointestinal Tumors: Is DNA Damage Reversible by Early Individualized Nutritional Support?
Liana M Bergholz, Peter Grimminger, Elsa Dikeoulia, et al.
Cancers
|
July 9, 2022
Integrative Analysis of Intrahepatic Cholangiocarcinoma Subtypes for Improved Patient Stratification: Clinical, Pathological, and Radiological Considerations
Tiemo S Gerber, Lukas Müller, Fabian Bartsch, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine
|
March 15, 2018
Cytokeratin-18 fragments predict treatment response and overall survival in gastric cancer in a randomized controlled trial
Michael Nagel, Julia Schulz, Annett Maderer, et al.
Journal of Cancer Research and Clinical Oncology
|
March 13, 2017
HER2 testing in gastric cancer: results of a German expert meeting
Florian Lordick, Salah-Eddin Al-Batran, Manfred Dietel, et al.
Eclinicalmedicine
|
May 28, 2026
Tislelizumab plus chemotherapy versus placebo plus chemotherapy as first-line treatment in patients with advanced gastric or gastroesophageal junction adenocarcinoma, with or without peritoneal metastases: a post-hoc analysis on RATIONALE-305 study
Miao-Zhen Qiu, Keun-Wook Lee, Markus Möhler, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association
|
October 17, 2023
German, Austrian, and Swiss guidelines for systemic treatment of gastric cancer
Florian Lordick, Salah-Eddin Al-Batran, Dirk Arnold, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 12, 2015
Impact of Subsequent Therapies on Outcome of the FIRE-3/AIO KRK0306 Trial: First-Line Therapy With FOLFIRI Plus Cetuximab or Bevacizumab in Patients With KRAS Wild-Type Tumors in Metastatic Colorectal Cancer
Dominik P Modest, Sebastian Stintzing, Ludwig Fischer von Weikersthal, et al.
BMC Cancer
|
April 13, 2012
LICC: L-BLP25 in patients with colorectal carcinoma after curative resection of hepatic metastases: a randomized, placebo-controlled, multicenter, multinational, double-blinded phase II trial
Carl Christoph Schimanski, Markus Möhler, Michael Schön, et al.
Page
of 3